| Stage | SCI | % of rev | MANH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $306M | 100.00% | SCI ×3.62 |
| Gross profit | $272M | 24.59% | $174M | 56.93% | MANH +32.3pp |
| Operating income | $253M | 22.84% | $81M | 26.45% | MANH +3.6pp |
| Pre-tax income | $189M | 17.05% | $83M | 27.07% | MANH +10.0pp |
| Net income | $141M | 12.76% | $61M | 20.03% | MANH +7.3pp |
| Stage | SCI | MANH | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $306M100.00% | SCI ×3.62 |
| Gross profit | 24.59%$272M | 56.93%$174M | MANH +32.3pp |
| Operating income | 22.84%$253M | 26.45%$81M | MANH +3.6pp |
| Pre-tax income | 17.05%$189M | 27.07%$83M | MANH +10.0pp |
| Net income |
| 12.76%$141M |
| 20.03%$61M |
| MANH +7.3pp |